Livestock Biotech

Driving livestock productivity using next-generation biotechnology

Overview

Livestock biotechnology (biotech) encompasses a range of scientific techniques and technologies—such as genetic engineering, reproductive technologies, and advanced diagnostics—to improve the health, productivity, and management of farm animals. A steady increase in meat consumption is driving biotech innovations targeting productivity and efficiency improvements, while the prevalence of animal diseases underscores the need for biotech solutions to improve animal health and disease resistance. Biotech practices also aim to reduce the environmental footprint of livestock production. 

Progress in the livestock biotech space has been slow due to strict regulations and low public acceptance of genetically engineered or modified meat products. Barriers to trade and international market access, particularly in the EU, further complicate the expansion of livestock biotech products on a global scale.

Industry Updates

View all updatesicon
Market Sizing

The US Livestock Biotech market could reach USD 2.8 billion–3.5 billion by 2028

Conservative case

USD 0.0 Bn

Base case

USD 0.0 Bn

Expansion case

USD 0.0 Bn

Use cases


The need to manage and improve overall health, productivity, and reproduction and reduce agricultural emissions, among others, is driving demand for livestock biotech solutions. Given the industry’s narrow scope, use cases are mostly aggregated in the Agricultural Products & Services and Packaged Foods & Meats subsegments (under Consumer Staples), while the Consumer Discretionary segment (specifically Education subsegment) also has some commercial uses.

Market Mapping


Biotech-enhanced feed additives companies are the most prevalent, followed by next-generation vaccines and drugs, precision breeding, and genetic engineering. However, precision breeding companies offer more commercialized solutions and have the most expansion-stage companies, while next-generation vaccines and drugs and biotech-enhanced feed additives have the most go-to-market-stage and minimum viable product-stage companies, respectively. The majority of the players focus on a singular area.

The Disruptors


Livestock biotech funding has been limited with no disruptor raising more than USD 50 million. Cytophage Technologies remains the only listed startup. Nevertheless, the biotech-enhanced feed additives segment has attracted the most funding, followed by next-generation vaccines and drugs, genetic engineering, and precision breeding.

Funding History

Competitive Analysis


Filter by a segment or companies of your choice
expand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

Incumbents


Key incumbents in the livestock biotech space include global health and nutrition companies like Thermo Fisher Scientific and Zoetis and food producers like ADM and Cargill as well as companies that focus solely on animal health and nutrition. Most incumbent activity is focused on the biotech-enhanced feed additives segment followed by the next-generation vaccines and drug segment. 

The industry’s acquisitions have focused on expanding reach within the sector and broadening portfolios to solidify market positions.

In House Development
M&A
Partnership
Investment
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Notable Investors


?
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.